XML 87 R62.htm IDEA: XBRL DOCUMENT v3.25.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Net Income for Earnings Per Share Calculations:                      
Income from continuing operations, net of tax $ 345.0 $ 362.1 $ 364.0 $ 324.9 $ 333.1 $ 334.9 $ 251.4 $ 300.6 $ 1,396.0 $ 1,220.0 $ 1,324.0
Net loss attributable to noncontrolling interests                 (4.9) (3.0) 0.0
Income from continuing operations attributable to Edwards Lifesciences Corporation                 1,400.9 1,223.0 1,324.0
Income from discontinued operations                 2,773.7 179.4 197.9
Net income attributable to Edwards Lifesciences Corporation. $ 385.6 $ 3,070.8 $ 366.3 $ 351.9 $ 369.9 $ 384.9 $ 307.1 $ 340.5 $ 4,174.6 $ 1,402.4 $ 1,521.9
Weighted Average Shares:                      
Basic weighted-average shares outstanding (in shares)                 597.7 606.7 619.0
Dilutive effect of stock plans (in shares)                 1.6 2.7 5.2
Diluted (in shares)                 599.3 609.4 624.2
Basic:                      
Continuing operations (in dollars per share) $ 0.58 $ 0.61 $ 0.61 $ 0.54 $ 0.55 $ 0.55 $ 0.42 $ 0.49 $ 2.34 $ 2.02 $ 2.14
Discontinued operations (in dollars per share) 0.07 4.53 0 0.04 0.06 0.08 0.09 0.07 4.64 0.29 0.32
Basic earnings per share (in dollars per share) 0.65 5.14 0.61 0.58 0.61 0.63 0.51 0.56 6.98 2.31 2.46
Diluted:                      
Continuing operations (in dollars per share) 0.58 0.61 0.61 0.54 0.55 0.55 0.41 0.49 2.34 2.01 2.12
Discontinued operations (in dollars per share)                 4.63 0.29 0.32
Diluted earnings per share (in dollars per share) $ 0.65 $ 5.13 $ 0.61 $ 0.58 $ 0.61 $ 0.63 $ 0.50 $ 0.56 $ 6.97 $ 2.30 $ 2.44